Key facts
- This page summarizes Christopher A. Morrison's Form 4 filing for Sanara MedTech Inc. (SMTI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 10 Mar 2022, 16:00.
Christopher A. Morrison - 01 Jan 2022 Form 4 Insider Report for Sanara MedTech Inc. (SMTI)
- Reporting relationship
- President - Telehealth Svcs.
- Issuer ticker
- SMTI
- Reported as of
- 01 Jan 2022
- Net transaction value
- $0
- Reporting owner signature
- /s/ Christopher A. Morrison
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Christopher A. Morrison filed Form 4 for Sanara MedTech Inc. (SMTI) on 10 Mar 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SMTI
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +7,135
- Change %
- +34%
- Price
- $0.000000
- Shares after
- 28,032
- Date
- 01 Jan 2022
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long Term Incentive Plan. The shares vest in four equal installments, with one-fourth of the shares vesting on April 1, 2022, and the remainder vesting in three equal installments on July 1, 2022, October 1, 2022, and January 1, 2023, respectively.